Position in ARGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$22,892,724
-$36,129,002 QoQ
Shares Held
24,675
-69.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#87
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. ARGX ranks #12 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,892,724 | 24,675 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $59,021,726 | 80,824 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $85,375,766 | 101,523 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $89,172,479 | 120,902 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $66,169,551 | 120,042 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $83,201,422 | 140,575 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $106,198,815 | 172,681 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $97,937,593 | 180,670 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $91,223,525 | 212,128 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $88,073,195 | 223,695 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $73,759,670 | 193,885 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $86,217,644 | 175,371 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $48,162,833 | 123,580 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $43,617,940 | 117,070 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $48,895,588 | 129,070 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $68,984,910 | 195,397 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $76,918,323 | 203,015 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $66,185,145 | 209,905 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $70,345,466 | 200,878 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $40,999,822 | 135,761 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $39,928,204 | 132,621 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $37,821,236 | 137,337 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $35,432,845 | 120,483 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,020,474 | 114,355 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $25,277,788 | 112,231 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,184,799 | 84,907 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||